LBT Innovations Limited (LBT.AX)
AUD 0.02
(N/A%)
AUD 0.02
(N/A%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -4.74 Million AUD | 33.62% |
| 2023 | -7.14 Million AUD | 9.61% |
| 2022 | -7.9 Million AUD | -27.32% |
| 2021 | -6.2 Million AUD | -7.58% |
| 2020 | -5.76 Million AUD | -10.5% |
| 2019 | -5.22 Million AUD | 34.99% |
| 2018 | -8.02 Million AUD | 9.21% |
| 2017 | -8.84 Million AUD | -301.57% |
| 2016 | 4.38 Million AUD | 2169.81% |
| 2015 | -212 Thousand AUD | 76.44% |
| 2014 | -900 Thousand AUD | -343.24% |
| 2013 | 370 Thousand AUD | 119.29% |
| 2012 | -1.91 Million AUD | 8.58% |
| 2011 | -2.09 Million AUD | -239.22% |
| 2010 | 1.5 Million AUD | 4332.35% |
| 2009 | 34 Thousand AUD | 119.1% |
| 2008 | -178 Thousand AUD | -112.13% |
| 2007 | 1.46 Million AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -2.69 Million AUD | 0.0% |
| 2024 FY | -4.74 Million AUD | 33.62% |
| 2024 Q2 | -1.89 Million AUD | 0.0% |
| 2023 Q2 | -3.98 Million AUD | 0.0% |
| 2023 Q4 | -2.93 Million AUD | 0.0% |
| 2023 FY | -7.14 Million AUD | 9.61% |
| 2022 FY | -7.9 Million AUD | -27.32% |
| 2022 Q4 | -4.25 Million AUD | 0.0% |
| 2022 Q2 | -3.3 Million AUD | 0.0% |
| 2021 Q4 | -3.23 Million AUD | 0.0% |
| 2021 FY | -6.2 Million AUD | -7.58% |
| 2021 Q2 | -2.96 Million AUD | 0.0% |
| 2020 Q2 | -2.99 Million AUD | 0.0% |
| 2020 Q4 | -2.77 Million AUD | 0.0% |
| 2020 FY | -5.76 Million AUD | -10.5% |
| 2019 FY | -5.22 Million AUD | 34.99% |
| 2019 Q4 | -1.42 Million AUD | 0.0% |
| 2019 Q2 | -2.53 Million AUD | 0.0% |
| 2018 FY | -8.02 Million AUD | 9.21% |
| 2018 Q4 | -1.75 Million AUD | 0.0% |
| 2018 Q2 | -1.74 Million AUD | 0.0% |
| 2017 Q2 | -758 Thousand AUD | 0.0% |
| 2017 Q4 | -10.32 Million AUD | 0.0% |
| 2017 FY | -8.84 Million AUD | -301.57% |
| 2016 Q2 | 3.68 Million AUD | 0.0% |
| 2016 Q4 | 699 Thousand AUD | 0.0% |
| 2016 FY | 4.38 Million AUD | 2169.81% |
| 2015 Q4 | -530 Thousand AUD | 0.0% |
| 2015 FY | -212 Thousand AUD | 76.44% |
| 2015 Q2 | 318 Thousand AUD | 0.0% |
| 2014 FY | -900 Thousand AUD | -343.24% |
| 2014 Q2 | 25 Thousand AUD | 0.0% |
| 2014 Q4 | -925 Thousand AUD | 0.0% |
| 2013 Q2 | -1.47 Million AUD | 0.0% |
| 2013 FY | 370 Thousand AUD | 119.29% |
| 2013 Q4 | 1.84 Million AUD | 0.0% |
| 2012 Q2 | -479.5 Thousand AUD | 8.58% |
| 2012 Q3 | -479.5 Thousand AUD | 0.0% |
| 2012 Q4 | -479.5 Thousand AUD | 0.0% |
| 2012 FY | -1.91 Million AUD | 8.58% |
| 2012 Q1 | -524.5 Thousand AUD | 0.0% |
| 2011 FY | -2.09 Million AUD | -239.22% |
| 2011 Q2 | -524.5 Thousand AUD | -239.22% |
| 2011 Q1 | 376.75 Thousand AUD | 0.0% |
| 2011 Q3 | -524.5 Thousand AUD | 0.0% |
| 2011 Q4 | -524.5 Thousand AUD | 0.0% |
| 2010 Q2 | 376.75 Thousand AUD | 4332.35% |
| 2010 FY | 1.5 Million AUD | 4332.35% |
| 2010 Q1 | 8500.00 AUD | 0.0% |
| 2010 Q4 | 376.75 Thousand AUD | 0.0% |
| 2010 Q3 | 376.75 Thousand AUD | 0.0% |
| 2009 Q4 | 8500.00 AUD | 0.0% |
| 2009 Q3 | 8500.00 AUD | 0.0% |
| 2009 Q1 | -44.5 Thousand AUD | 0.0% |
| 2009 Q2 | 8500.00 AUD | 119.1% |
| 2009 FY | 34 Thousand AUD | 119.1% |
| 2008 Q2 | -44.5 Thousand AUD | -112.13% |
| 2008 Q3 | -44.5 Thousand AUD | 0.0% |
| 2008 FY | -178 Thousand AUD | -112.13% |
| 2008 Q4 | -44.5 Thousand AUD | 0.0% |
| 2008 Q1 | 366.79 Thousand AUD | 0.0% |
| 2007 Q3 | 366.79 Thousand AUD | 0.0% |
| 2007 FY | 1.46 Million AUD | 0.0% |
| 2007 Q2 | 366.79 Thousand AUD | 0.0% |
| 2007 Q4 | 366.79 Thousand AUD | 0.0% |
| 2006 Q1 | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 83.051% |
| Adherium Limited | -11.98 Million AUD | 60.452% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 51.572% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -8.679% |
| Anteris Technologies Ltd | -66.63 Million AUD | 92.886% |
| Control Bionics Limited | -5.92 Million AUD | 20.058% |
| CardieX Limited | -4.63 Million AUD | -2.294% |
| Compumedics Limited | -269 Thousand AUD | -1662.082% |
| Cochlear Limited | 521.5 Million AUD | 100.909% |
| CleanSpace Holdings Limited | -4.81 Million AUD | 1.536% |
| Cyclopharm Limited | -9.22 Million AUD | 48.616% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -193.606% |
| Nova Eye Medical Limited | -3.79 Million AUD | -24.835% |
| HeraMED Limited | -6.42 Million AUD | 26.26% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 73.03% |
| ImpediMed Limited | -19.03 Million AUD | 75.1% |
| InhaleRx Limited | -1.38 Million AUD | -241.871% |
| Micro-X Limited | -13.02 Million AUD | 63.614% |
| Neurotech International Limited | -5.58 Million AUD | 15.127% |
| OncoSil Medical Limited | -11.98 Million AUD | 60.448% |
| PolyNovo Limited | 1.16 Million AUD | 507.567% |
| Respiri Limited | -7 Million AUD | 32.288% |
| SomnoMed Limited | -3.84 Million AUD | -23.396% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 71.583% |
| Uscom Limited | -2.4 Million AUD | -97.143% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | 19.031% |